ANDA 88432, held by Icu Medical Inc. Meperidine Hydrochloride.
As of Nov 16, 2026, ANDA 88432 (Meperidine Hydrochloride Preservative Free), held by Icu Medical Inc, was first approved by FDA on Aug 16, 1984, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 16, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Meperidine Hydrochloride Preservative Free10MG/ML · injectable;injection | Meperidine Hydrochloride | DiscontinuedReference drug |
| Dec 16, 2016 | Supplement 21Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 20Labeling · Standard review | Approved | None posted |
| Jul 22, 1999 | Supplement 12Manufacturing | Approved | None posted |
| Aug 16, 1995 | Supplement 10Manufacturing | Approved | None posted |
| Aug 16, 1995 | Supplement 9Manufacturing | Approved | None posted |
| Jun 30, 1992 | Supplement 7Labeling | Approved | None posted |
| Mar 6, 1992 | Supplement 3Labeling | Approved | None posted |
| Aug 28, 1985 | Supplement 1Manufacturing | Approved | None posted |
| Aug 16, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters